Crispr Therapeutics Ag Stock Performance
as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
$55.1$56.49
2.10%
Downside
0.37%
Upside
52 Week's Low
52 Week's High
$30.04$71.1346.62%
Downside
26.39%
Upside
Crispr Therapeutics Ag share price movements today
- Previous Close
- $55.89
- Open
- $56.12
- Volume
- 1.5M
- Day's Low - High
- $55.1 - $56.49
- 52 Week Low - High
- $30.04 - $71.13
Crispr Therapeutics Ag Historical Returns
- 1 Month Return
- -1.87 %
- 3 Month Return
- + 36.03 %
- 1 Year Return
- + 14.96 %
- 3 Year Return
- -16.71 %
- 5 Year Return
- -29.66 %
Crispr Therapeutics Ag Stock Fundamentals & Key Indicators
Check Crispr Therapeutics Ag market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.1B
EPS (TTM)
-6.1416
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-15.21
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
-0.2142
EBITDA
-437.2M
Revenue (TTM)
38.0M
Profit Margin
0.00%
Return On Equity TTM
3285500.00%
Crispr Therapeutics Ag Stock Valuation
Track how Crispr Therapeutics Ag P/E has moved over time to understand its valuation trends.
Crispr Therapeutics Ag in the last 5 years
Lowest (17.39x)
March 31, 2022
Today (-15.21x)
September 13, 2025
Industry (10.13x)
September 13, 2025
Highest (26.38x)
September 30, 2021
Today’s Price to Earnings Ratio: -15.21x
Crispr Therapeutics Ag vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Crispr Therapeutics Ag with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $5.1B | -29.66% | -15.21 | 0.00% | |
| BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
| NA | $37.7B | NA | NA | -3.89% | |
| BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
| BUY | $59.4B | 2.03% | 14.11 | 31.37% |
Stock Returns calculator for Crispr Therapeutics Ag Stock including INR - Dollar returns
The Crispr Therapeutics Ag stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Crispr Therapeutics Ag investment value today
Current value as on today
₹1,20,137
Returns
₹20,137
(+20.14%)
Returns from Crispr Therapeutics Ag Stock
₹14,998 (+15%)
Dollar Returns*
₹5,139 (+5.14%)
Analyst Recommendation on Crispr Therapeutics Ag Stock
Based on 35 analysts
54.29%
Buy
37.14%
Hold
8.57%
Sell
Based on 35 analysts, 54.29% of analysts recommend a 'BUY' rating for Crispr Therapeutics Ag. Average target price of $81.23
Crispr Therapeutics Ag Share Price Target
Get share price movements and forecasts by analysts on Crispr Therapeutics Ag.
What analysts predicted
30.72%UPSIDE
Target Price
$81.23
Current Price
$56.28
Analyzed by
35 Analysts
Target
$81.23
Crispr Therapeutics Ag target price $81.23, a slight upside of 30.72% compared to current price of $56.28. According to 35 analysts rating.
Crispr Therapeutics Ag Stock's Interest Amongst Investors
Investment in Crispr Therapeutics Ag Shares on INDmoney has dropped by -43.82% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Crispr Therapeutics Ag Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Crispr Therapeutics Ag Quarterly Profit & Loss
All numbers in Millions USD
Crispr Therapeutics Ag Annual Profit & Loss
All numbers in Millions USD
Crispr Therapeutics Ag Quarterly Cash Flow
All numbers in Millions USD
Crispr Therapeutics Ag Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Crispr Therapeutics Ag
Insights on Crispr Therapeutics Ag
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 865.0K → 892.0K (in $), with an average increase of 3.0% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 60.7%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 145.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -37.31M → -208.54M (in $), with an average decrease of 158.9% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, CRSP stock has moved down by -4.3%
About Crispr Therapeutics Ag
| Organisation | Crispr Therapeutics Ag |
| Headquarters | Baarerstrasse 14, Zug, Switzerland, 6300 |
| Industry | Health Technology |
| CEO | Dr. Samarth Kulkarni Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Crispr Therapeutics Ag
Name | Title |
|---|---|
Dr. Craig C. Mello Ph.D. | Scientific Founder & Advisory Board Member |
Dr. Chad A. Cowan Ph.D. | Scientific Founder |
Dr. Samarth Kulkarni Ph.D. | CEO & Chairman |
Dr. Raju Yashaswi Prasad Ph.D. | Chief Financial Officer |
Mr. Shaun Foy CFA | Founder |
Dr. Emmanuelle Marie Charpentier Ph.D. | Co-Founder & Scientific Advisory Board Member |
Mr. James R. Kasinger J.D. | General Counsel & Secretary |
Dr. Naimish Patel C.M., M.D. | Chief Medical Officer |
Dr. Matthew Porteus M.D., Ph.D. | Scientific Founder & Advisory Board Member |
Dr. Daniel G. Anderson Ph.D. | Scientific Founder & Advisory Board Member |
FAQs
What is Crispr Therapeutics Ag share price today?
Crispr Therapeutics Ag share price today is $56.28 as on at the close of the market. Crispr Therapeutics Ag share today touched a day high of $56.49 and a low of $55.1.
What is the 52 week high and 52 week low for Crispr Therapeutics Ag share?
Crispr Therapeutics Ag share touched a 52 week high of $71.13 on and a 52 week low of $30.04 on . Crispr Therapeutics Ag stock price today i.e. is closed at $56.28,which is 20.88% down from its 52 week high and 87.35% up from its 52 week low.
What is Crispr Therapeutics Ag's market capitalisation today?
Crispr Therapeutics Ag market capitalisation is $0.01T as on .
How to invest in Crispr Therapeutics Ag Stock (CRSP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Crispr Therapeutics Ag on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crispr Therapeutics Ag Shares that will get you 0.0267 shares as per Crispr Therapeutics Ag share price of $56.28 per share as on September 13, 2025 at 1:29 am IST.
What is the minimum amount required to buy Crispr Therapeutics Ag Stock (CRSP) from India?
Indian investors can start investing in Crispr Therapeutics Ag (CRSP) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Crispr Therapeutics Ag stock (as per the Rupee-Dollar exchange rate as on ).
Based on Crispr Therapeutics Ag share’s latest price of $56.28 as on September 13, 2025 at 1:29 am IST, you will get 0.1777 shares of Crispr Therapeutics Ag. Learn more about
fractional shares .
What are the returns that Crispr Therapeutics Ag has given to Indian investors in the last 5 years?
Crispr Therapeutics Ag stock has given -29.66% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?